1/3/2020Cash-strapped Leap Therapeutics Signs Collaboration Deal with BeiGene

1/3/2020Meeting Clinical Trial Data Requirements In Asian Markets

1/3/2020CDMO WuXi STA Opens Manufacturing Facility to Produce Oligonucleotides

1/3/2020NHC Issues the Clinical Pathways for Relevant Disease Groups (2019)

1/3/2020Amgen Closes Acquisition of 20.5% Stake in BeiGene for $2.8B

1/2/2020U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Mi...

1/2/2020NHC and SATCM Issues Rules for Internal Price Practices of Medical Ins...

1/2/2020AstraZeneca Granted Chinese Approval for Its Hyperkalaemia Drug ZS-9

12/31/2019China Jails Three Researchers Involved in Gene-edited Babies

12/31/2019Financial-related Company News in Brief

12/31/2019NMPA Announces Initiation of Drug Business Application System

12/31/2019NMPA Issues Guiding Principles for Classification Standards for ADRs o...

12/30/2019Bankrupt Achaogen Sells China Assets to Xuanzhu for $4.5M

12/30/2019China's 'Seaweed' Alzheimer's Drug Is Now Available to Patients

12/30/2019NMPA Issues the Principles and Procedures for Drug Sampling

12/30/2019Boehringer Ingelheim Approved to Manufacture Tislelizumab in China for...

12/29/2019Document for New Round of National Level Centralized Drug Purchase Tri...

12/29/2019China Adopts New Law to Promote Basic Medical and Health Care

12/27/2019Recent Executive Moves

12/27/2019China Launches Mental Health Initiative for Students

12/27/2019Luye Pharma Submits New Drug Application in the U.S. for Its Antidepre...

12/27/2019Bridge and Daewoong Announces NMPA Clearance of IND for BBT-401, a Pel...

12/27/2019Zai Lab Announces NMPA Approval of ZEJULA (Niraparib) as Maintenance T...

12/27/2019JT and Salubris Pharma Enter Licensing Pact for HIF-PHI Inhibitor Enar...

12/27/2019NMPA Initiates Drug Import & Export Permit Management System

12/27/2019Janssen Secured Chinese Approval of Psoriasis Drug Tremfya (Gussetizum...

12/26/2019Sanofi Files NDA for the World's Atopic Dermatitis Biologic Dupilumab ...

12/26/2019CStone Pharma to Submit NDA for Anticancer Pralsetinib Next Year

12/26/2019China Lists Lemazolam for Regulation as Class 2 Psychotropic

12/25/2019CDE Solicits Comments on Guidelines for Clinical Protocol of Biosimila...

Page:282/803 Total number of articles:24087: [First][<<] [280] [281] [282] [283] [284] [>>] [End]